| Similarity-based modeling in large-scale prediction of drug-drug interactions S Vilar, E Uriarte, L Santana, T Lorberbaum, G Hripcsak, C Friedman, ... Nature protocols 9 (9), 2147-2163, 2014 | 305 | 2014 |
| Disease heritability inferred from familial relationships reported in medical records FCG Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, ... Cell 173 (7), 1692-1704. e11, 2018 | 121 | 2018 |
| Coupling data mining and laboratory experiments to discover drug interactions causing QT prolongation T Lorberbaum, KJ Sampson, JB Chang, V Iyer, RL Woosley, RS Kass, ... Journal of the American College of Cardiology 68 (16), 1756-1764, 2016 | 94 | 2016 |
| Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms MR Boland*, A Jacunski*, T Lorberbaum*, JD Romano, R Moskovitch, ... Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2015 | 54 | 2015 |
| Systems pharmacology augments drug safety surveillance T Lorberbaum, M Nasir, MJ Keiser, S Vilar, G Hripcsak, NP Tatonetti Clinical Pharmacology & Therapeutics 97 (2), 151-158, 2015 | 53 | 2015 |
| A computational drug repositioning approach for targeting oncogenic transcription factors KM Gayvert, E Dardenne, C Cheung, MR Boland, T Lorberbaum, ... Cell reports 15 (11), 2348-2356, 2016 | 47 | 2016 |
| An integrative data science pipeline to identify novel drug interactions that prolong the QT interval T Lorberbaum, KJ Sampson, RL Woosley, RS Kass, NP Tatonetti Drug safety 39 (5), 433-441, 2016 | 45 | 2016 |
| Improving detection of arrhythmia drug-drug interactions in pharmacovigilance data through the implementation of similarity-based modeling S Vilar, T Lorberbaum, G Hripcsak, NP Tatonetti PloS one 10 (6), e0129974, 2015 | 27 | 2015 |
| Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data RD Boyce, EA Voss, V Huser, L Evans, C Reich, JD Duke, NP Tatonetti, ... Journal of Biomedical Semantics 8 (11), 2017 | 17 | 2017 |
| Comparative analysis, applications, and interpretation of electronic health record-based stroke phenotyping methods PM Thangaraj, BR Kummer, T Lorberbaum, MSV Elkind, NP Tatonetti BioData mining 13 (1), 21, 2020 | 14 | 2020 |
| Estimate of disease heritability using 7.4 million familial relationships inferred from electronic health records F Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, H Salmasian, ... BiorXiv, 066068, 2016 | 9 | 2016 |
| Health event logging and coaching user interfaces RB KUMAR, SH Bui, L CHATTA, KD VARBEL, JP DOBSON, SP Hendee, ... US Patent 12,400,765, 2025 | 3 | 2025 |
| User interfaces for logging user activities A NARRA, JP DOBSON, O Golfetto, SP Hendee, RB KUMAR, ... US Patent 12,164,748, 2024 | 1 | 2024 |
| User interfaces for logging user activities A NARRA, JP DOBSON, SP Hendee, RB KUMAR, T Lorberbaum, ... US Patent 11,698,710, 2023 | 1 | 2023 |
| Discovering new drug-drug interactions using data science: Applications to drug-induced Long QT Syndrome T Lorberbaum Columbia University, 2017 | 1 | 2017 |
| User interfaces for logging user activities A NARRA, JP DOBSON, O Golfetto, SP Hendee, RB KUMAR, ... US Patent App. 18/972,766, 2025 | | 2025 |
| User interfaces for logging user activities A NARRA, JP DOBSON, O Golfetto, SP Hendee, RB KUMAR, ... US Patent 12,001,648, 2024 | | 2024 |
| Predicting the genetic ancestry of 2.6 million New York City patients using clinical data V Ramlall, KM Quinnies, R Vanguri, T Lorberbaum, DB Goldstein, ... bioRxiv, 768440, 2019 | | 2019 |
| Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk T Lorberbaum, NP Tatonetti Journal of the American College of Cardiology 69 (14), 1877-1878, 2017 | | 2017 |
| Estimate of disease heritability using 7.4 million familial relationships inferred from F Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, H Salmasian, ... JAMA 315, 68-9, 2016 | | 2016 |
Nicholas P TatonettiProfessor and Vice Chair of Computational Biomedicine, Cedars-Sinai Medical CenterVerified email at cshs.org
